medical prevention of occupational risks of infection
play

Medical prevention of occupational risks of infection Marie-Ccile - PowerPoint PPT Presentation

EFICATT Medical prevention of occupational risks of infection Marie-Ccile BAYEUX-DUNGLAS Medical Advisor INRS Paris- FRANCE Dsseldorf 21.10.2011 www.issa.int Accidental exposure to infectious agents in the workplace Infectious risk


  1. EFICATT Medical prevention of occupational risks of infection Marie-Cécile BAYEUX-DUNGLAS Medical Advisor INRS Paris- FRANCE Düsseldorf 21.10.2011 www.issa.int

  2. Accidental exposure to infectious agents in the workplace � Infectious risk following accidental exposure to biological agents in the workplace has rarely been studied (apart from a few specific risks) � Specific importance of post exposure measures � Elaboration of a guide on the actions to be taken 2 www.issa.int Düsseldorf 21.10.2011

  3. EFICATT: Background � 2001: Agreement between The French Research and Safety Institute for the Prevention of Occupational Accidents and Diseases (INRS) and the study group on healthcare workers’ exposure to infectious risks (GERES) � Aim: to build a concise reference tool with consensus-based recommendations for actions to be taken � 2004: Setting up of the working group Editorial Committee Scientific Committee www.issa.int Düsseldorf 21.10.2011 3

  4. INRS in brief � Articles of association � A non-profit organisation � A joint Board of Directors with staff and management equally represented � An independent Scientific Committee � Purpose: to develop occupational risk prevention � Preserving health and safety at work, developing prevention solutions for the benefit of all the players in the working world � Funding � National Fund for the Prevention of Occupational Accidents and Diseases of the CNAM-TS, financed by company contributions 4 www.issa.int Düsseldorf 21.10.2011

  5. GERES in brief � A non-profit university-based research group for the prevention of occupational infections among health care workers (HCWs) � founded in 1991 GERES - Faculté Médecine BICHAT 16 rue Henri Huchard, 75018 Paris, France. Tél : (33) 1 57 27 78 70 - Fax : (33) 1 57 27 77 01 e-mail: geres@geres.org – web site: www.geres.org 5 www.issa.int Düsseldorf 21.10.2011

  6. EFICATT: Editorial Committee INRS GERES Geneviève ABADIA Elisabeth BOUVET Marie-Cécile BAYEUX-DUNGLAS Dominique ABITEBOUL � Role of the Editorial Committee: � Schedule the drafting of data sheets by order of priority � Select authors in agreement with the Scientific Committee � Follow up the data sheet drafting with the authors � Harmonise contributions to ensure consistency www.issa.int Düsseldorf 21.10.2011 6

  7. EFICATT: Scientific Committee � Comprising physicians specialised in different fields Infectious diseases, Occupational medicine, Hospital hygiene, Bacteriology, Virology… � Roles of the Scientific Committee Assist the Editorial Committee in the scientific approach Validate the data sheets submitted by the authors www.issa.int Düsseldorf 21.10.2011 7

  8. EFICATT: aim � Concise reference tool targeted at all physicians � Bringing together scientific elements and valuable official recommendations � Support for risk assessment � Serves to define � the immediate action to be taken � subsequent actions to be taken � medical follow-up to be implemented www.issa.int Düsseldorf 21.10.2011 8

  9. The EFICATT guide � Online database � Data sheets divided into 4 sections: Pathogen and pathology Procedure to follow in the event of exposure The specific case of laboratory exposure References � 2006: Publication of the first data sheet www.issa.int Düsseldorf 21.10.2011 9

  10. 10 www.inrs.fr/eficatt www.issa.int EFICATT Guide Düsseldorf 21.10.2011

  11. 11 11 www.issa.int Data sheet reading guide Düsseldorf 21.10.2011

  12. 12 www.issa.int Düsseldorf 21.10.2011

  13. 13 www.issa.int Düsseldorf 21.10.2011

  14. Pathogen and pathology � Reservoir � Infectivity � Epidemiological data � Transmission, incubation, clinical signs, diagnosis, treatment � Vaccine prevention � Populations at risk � Pregnancy www.issa.int Düsseldorf 21.10.2011 14

  15. Procedure to follow in the event of exposure � Definition of who must be considered as exposed � Risk assessment � Immediate action to be taken � Prophylactic measures � Medical follow-up � Reference texts www.issa.int Düsseldorf 21.10.2011 15

  16. The specific case of laboratory exposure � Published cases � Particularity of the risk assessment � Effect on the action to be taken www.issa.int Düsseldorf 21.10.2011 16

  17. EFICATT: References Direct links to regulatory reference documents www.issa.int Düsseldorf 21.10.2011 17

  18. EFICATT prospects � Regular data sheet updates � New sheets to be added: � Adenovirus conjunctivitis � Pediculosis � Chikungunya, etc. www.issa.int Düsseldorf 21.10.2011 18

  19. EFICATT Guide: conclusion � Online at www.inrs.fr/eficatt � 33 sheets currently available (in French only) Thank you for your attention www.issa.int Düsseldorf 21.10.2011 19

Recommend


More recommend